Skip to main content
The Egyptian Journal of Bronchology
Download PDF

Role of nebulized heparin inhalation on mechanically ventilated critically ill patients

Egyptian Journal of Bronchology volume 10, pages 179–188 (2016)Cite this article

Abstract

Introduction

Mechanical ventilation is one of the most important tools in the treatment of respiratory failure in critically ill patients, but it may cause lung injury and inflammatory response in the whole body.

Aim of work

The aim of our study was to justify the effect of nebulized heparin on morbidity, oxygenation parameters, lung mechanics, and mortality in mechanically ventilated critically ill patients who are assumed to require mechanical ventilation for more than 48 h for different indications.

Patients and methods

This study was conducted on 50 ICU patients who were in need of mechanical ventilation for more than 48 h. They were grouped randomly into two groups. One of the two groups was given nebulized heparin sodium until weaning or for a maximum of 14 days. Patients with coagulopathy or scheduled for any invasive intervention that may lead to bleeding were excluded. In addition, patients who were weaned or who died before day 4of admission were also excluded. Both groups were followed up for a maximum of 28 days. The study medication was reduced or withheld if any significant bleeding occurred. The endpoint results were primary oxygenation parameters [mainly arterial oxygen partial pressure (PaO2)/inspired oxygen fraction (FIO2)] and ventilator-free days. All other data were recorded and analyzed to find out the adverse positive effect of heparin nebulization.

Results

Data analysis revealed that the following data showed no statistically significant difference within groups over time or between the two groups: PaCO2, pH, PaO2, HCO3, SO2, PaO2/FIO2, FIO2×mean airway pressure/PaO2, peak inspiratory pressure, mean airway pressure, tumor necrosis factor α , systolic blood pressure, diastolic blood pressure, hemoglobin, hematocrit value, white blood cells count, platelet count, prothrombin concentration, international normalized ratio, presence of bloody sputum, ICU-free days at day 28, ventilator-free days at day 28, acute renal failure-free days at day 28, vasopressor-free days at day 28, and mortality and sputum culture results at day 4. However, the following data showed a statistically significant difference in the heparin-treated group: plateau pressure showed a statistically significant decrease between days 1 and 4 in the heparin-treated group (P=0.003) and a statistically significant difference when we compared the percentage change between the two groups (P=0.015). Compliance rate showed a statistically significant increase between days 1 and 4 in the heparin-treated group (P=0.019) but when we compared the percentage change between the two groups the difference was not statistically significant (P=0.256). Activated partial thromboplastin time showed a statistically significant increase between days 1 and 4 in the heparin-treated group (P=0.001), but when we compared the percentage change between the two groups the difference was not statistically significant (P=0.153). No cases of heparin-induced thrombocytopenia was noted in the heparin-treated group, nor was there major bleeding or need for blood transfusion related to the tested medication in this group.

Conclusion

We recommend nebulized heparin as a safe drug that has a favorable effect in patients receiving mechanical ventilation especially with reduced compliance as in cases of acute respiratory distress syndrome.

References

  1. Mahmood NA, Chaudry FA, Azam H, Ali MI, Khan MA. Frequency of hypoxic events in patients on a mechanical ventilator. Int J Crit Illn Inj Sci 2013;3:124–129.

    Article  Google Scholar 

  2. Tremblay LN, Slutsky AS. Ventilator-induced lung injury: from the bench to the bedside. Intensive Care Med 2006;32:24–33.

    Article  Google Scholar 

  3. Herrera MT, Toledo C, Valladares F, Muros M, Díaz-Flores L, Flores C, Villar J. Positive end-expiratory pressure modulates local and systemic inflammatory responses in a sepsis-induced lung injury model. Intensive Care Med 2003;29:1345–1353.

    Article  Google Scholar 

  4. Parsons PE, Matthay MA, Ware LB. Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol 2005;288:L426e31.

  5. Agouridakis P, Kyriakou D, Alexandrakis MG. The predictive role of serum and bronchoalveolar lavage cytokines and adhesion molecules for acute respiratory distress syndrome development and outcome. Respir Res 2002;3:25.

    Article  Google Scholar 

  6. Thourani VH, Sukhdev SB, Kennedy TP, Thornton LR, Watts JA, Ronson RS. Nonanticoagulant heparin inhibits NK-κB activation and attenuates myocardial reperfusion injury. Am J Physiol Heart Circ Physiol 2000;278: H2084–H2093.

    Article  CAS  Google Scholar 

  7. Li S, Zheng Z, Li X, Xiochun M. Unfractionated heparin inhibits lipopolysaccharide-induced response through blocking p38 MAPK and NF-KB activation on endothelial cells. Cytokine 2012;60:114–121.

    Article  CAS  Google Scholar 

  8. Lever R, Lo WT, Faraidoun M. Size-fractionated heparins have differential effects on human neutrophil function in vitro. Br J Pharmacol 2007;151:837–843.

    Article  CAS  Google Scholar 

  9. Fritzsche J, Alban S, Ludwig RJ. The influence of various structural parameters of semisynthetic sulfated polysaccharides on the P-selectin inhibitory capacity. Biochem Pharmacol 2006;72:474–485.

    Article  CAS  Google Scholar 

  10. Stawicki SP. Mechanical ventilation: weaning and extubation. OPUS Scientist 2007;1:13–16.

    Google Scholar 

  11. Dixon B, Schultz MJ, Smith R, Fink JB, Santa-Maria JD, Campbell DJ. Nebulized heparin is associated with fewer days of mechanical ventilation in critically ill patients: a randomized controlled trial. Crit Care 2010;14: R180.

    Article  Google Scholar 

  12. Li L, Huang CC, Lin HC, Tsai1 YH, Quinn DA, Liao SK. Unfractionated heparin and enoxaparin reduce high-stretch ventilation augmented lung injury: a prospective, controlled animal experiment. Crit Care 2009;13: R108.

    Article  Google Scholar 

  13. Dixon B, Santamaria JD, Campbell DJ. A phase 1 trial of nebulized heparin in acute lung injury. Crit Care 2008;12:R64.

    Article  Google Scholar 

  14. Murakami K, McGuire R,Cox RA, Jodoin JM, Bjertnaes LJ, Katahira J et al. Heparin nebulization attenuates acute lung injury in sepsis following smoke inhalation in sheep. Shock 2002;18:236–241.

    Article  Google Scholar 

  15. Hofstra JJ, Vlaar AP, Cornet AD, Dixon B, Roelofs JJ, Choi G et al. Nebulized anticoagulants limit pulmonary coagulopathy, but not inflammation, in a model of experimental lung injury. J Aerosol Med Pulm Drug Deliv 2009;23:105–111.

    Article  Google Scholar 

  16. Murakami K, Enkhbaatar P, Shimoda K, Mizutani A, Cox RA, Schmalstieg FC et al. High-dose heparin fails to improve acute lung injury following smoke inhalation in sheep. Clin Sci 2003;104:349–356.

    Article  CAS  Google Scholar 

  17. Yip LY, Lim YF, Chan HN. Safety and potential anticoagulant effects of nebulized heparin in burns patients with inhalational injury at Singapore General Hospital Burns Centre. Burns 2011;37:1154–1160.

    Article  Google Scholar 

  18. Ahmed T, Garrigo J, Danta I. Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin. N Engl J Med 1993;329:90–91.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Chest Medicine, Faculty of Medicine, Beni-suef University, Egypt

    Randa S. Mohammad

  2. Department of Critical Care Medicine, Faculty of Medicine, Beni-suef University, Egypt

    Sameh K. El-Maraghi

  3. Department of Chest Medicine, Faculty of Medicine, Helwan University, 27 Omar Bakeer Street, Saint Fatima Square, Heliopolis, Cairo, 11361, Egypt

    Waleed M. El-Sorougi (Assisstant Professor)

  4. Department of Critical Care, Medicine Faculty of Medicine, Beni-suef University, Egypt

    Sherif M. Sabri

  5. Department of Chest Medicine, Faculty of Medicine, Beni-suef University, Egypt

    Mohammad F. Mohammad

Authors
  1. Randa S. Mohammad
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sameh K. El-Maraghi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Waleed M. El-Sorougi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sherif M. Sabri
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mohammad F. Mohammad
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Waleed M. El-Sorougi.

Additional information

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mohammad, R.S., El-Maraghi, S.K., El-Sorougi, W.M. et al. Role of nebulized heparin inhalation on mechanically ventilated critically ill patients. Egypt J Bronchol 10, 179–188 (2016). https://doi.org/10.4103/1687-8426.184374

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/1687-8426.184374

Keywords